Acute gait disturbance associated with pamidronate infusion

Australian and New Zealand Journal of Medicine

Volumn 27, Issue 6, 1997, Pages 719-720

  Karapetis, C S ^a   Kotasek, D ^a   Norman, J E ^a   Sage, R E ^a  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PAMIDRONIC ACID;

AGED; ARTICLE; CASE REPORT; DRUG EFFECT; FEMALE; GAIT DISORDER; HUMAN; MYALGIA; OSTEOLYSIS;

EID: 0031407369     PISSN: 00048291     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.1997.tb01014.x     Document Type: Article

References (5)

1. Fleisch H, Russel RGG, Francis MD. Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo. Science 1969; 165: 1262-64.
2. van Breukelen FJM, Bijvoet OLM, van Oosterom. Inhibition of osteolytic bone lesions by (3-amino-1-hydroxy propylidene)-1, 1-bisphosphonate (APD). Lancet 1979; i; 803-5.
3. Adami S, Zamberlan N. Adverse effects of bisphosphonates. A comparative review. Drug Safety (NZ) 1996; 14: 584-5.
4. Reid IR, Mills DA, Wattle DJ. Ototoxicity associated with intravenous bisphosphonate administration. Calcif Tissue Int 1995; 56: 584-5.
5. Hortobagyi GN, Theriault RL, Porter L, Blayney D, Lipton A et al. Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. N Engl J Med 1996; 335: 1785-91.